Skip to content
Home/Companies/Biotech/Nostos Genomics
NG

Nostos Genomics

Biotech·Germany·Active·4yr hold

Nostos Genomics is a biotech company, headquartered in Germany.

Entry
2022
Hold
4yr
Status
Active
Est. EV
–

Who owns Nostos Genomics?

Nostos Genomics is currently owned by 42CAP through 42CAP II (2019 vintage), since 2022.

Hand-verified · updated 2026-07-16

42CAP
Investor
42CAP
42CAP II · 2019 · VC

Key facts

HQGermany
SectorBiotech
StatusActive

More from 42CAP II

Other portfolio companies in the same fund.

Cognee
Active
SoftwareGermany· 2026
SimplyBlock
Active
Cloud InfrastructureGermany· 2024
DBTune
Active
Data & AnalyticsSweden· 2023
Inceptron
Active
Deep TechSweden· 2023
KYP.ai
Active
Data & AnalyticsGermany· 2023
Osavul
Active
CybersecurityUkraine· 2023

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
2NA FISH
Active
Gruenderfonds RuhrGermany· 2026
Data refreshed weekly · Sourced from public filings